There is no issue with BIO's leading position in the Desci track. It is normal for the primary private placement and secondary public offering to sell off part of their profits shortly after going online. The concept is fine; we can look for opportunities to buy some after it stabilizes. You might consider around 0.5, which has a good cost-performance ratio.
